Fact sheet: Franklin Biotech Disc

Fund information

Fund name
Franklin Biotechnology Discovery A Acc USD
Fund company manager
Franklin Temp Intnl Serv SARL
Fund type
SIB
Fund manager(s)
Evan McCulloch
since 01/11/2000
Steve Kornfeld
since 15/09/2015
Fund objective
The Fund aims to achieve capital appreciation by investing principally in equity securities of biotechnology companies and discovery research firms mainly located in the US.
Benchmark
NASDAQ Biotechnology
Investment style
Growth
Investment method
Shares

Performance snapshot

Sector
Fund
Sector
Fund
Sector
Fund

Quick stats

1 Year return

2.26 %

1 Year rank in sector

24/29

Sector

FO Equity - Pharma Health & Biotech

Yield
-
Fund size

£ 2.4 b

FE Risk score

233

NAV
-
Discount/Premium
-
Gearing
-

Top in sector

Holdings snapshot

  • USA
    93.65%
  • Money Market
    6.35%
  • Equities
    93.65%
  • Cash & Cash Equivalents
    6.35%
  • US Equities
    93.65%
  • Cash & Cash Equivalents
    6.35%

Performance vs. Sector

Sector
Fund
Sector
Fund
Sector
Fund

Cumulative performance

1m6m1y3y5y
Fund-10.86 %0.81 %2.26 %1.84 %118.19 %
Sector-4.54 %0.79 %7.8 %12.47 %100.07 %
Rank within sector30 / 3018 / 3024 / 2919 / 268 / 22
Quartile th4 th3 rd4 th3 rd2 nd

Calendar performance

YTD-20172016201520142013
Fund10.38 %-17.88 %4.94 %34.71 %64.27 %
Sector11.8 %-9.92 %7.24 %28.08 %41.03 %
Rank within sector19 / 2925 / 2919 / 2612 / 231 / 22
Quartile th3 rd4 th3 rd3 rd1 st

Risk statistics

Alpha-4.62
Beta1.5
Sharpe-0.01
Volatility25.03
Tracking error13.11
Information ratio-0.3
R-Squared0.83

Price movement

52 week high34.08
52 week low27.06
Current bid price0
Current offer price0
Current mid price30.33

Holdings by region

  • 93.65% USA
  • 6.35% Money Market

Holdings by sector

  • 93.65% Equities
  • 6.35% Cash & Cash Equivalents

Holdings by asset type

  • 93.65% US Equities
  • 6.35% Cash & Cash Equivalents

Individual holdings

  • 7.07% CELGENE CORP
  • 6.98% ALEXION PHARMACEUTICALS INC
  • 4.93% BIOGEN INC
  • 4.91% INCYTE CORP
  • 4.4% ILLUMINA INC
  • 4.29% REGENERON PHARMACEUTICALS INC
  • 4.28% GILEAD SCIENCES INC
  • 3.92% VERTEX PHARMACEUTICAL
  • 3.63% NEUROCRINE BIOSCIENCES INC
  • 3.24% CLOVIS ONCOLOGY INC